Renaissance Technologies
WHWK

Renaissance Technologies’s Whitehawk Therapeutics WHWK Stock Holding History

Renaissance Technologies’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.48M Sell
428,622
-12,100
-3% -$37.9K ﹤0.01% 2055
2025
Q4 		$1.07M Sell
440,722
-16,700
-4% -$38.3K ﹤0.01% 2237
2025
Q3 		$869K Sell
457,422
-800
-0.2% -$1.47K ﹤0.01% 2560
2025
Q2 		$857K Sell
458,222
-3,900
-0.8% -$6.79K ﹤0.01% 2585
2025
Q1 		$823K Buy
462,122
+6,100
+1% +$15.9K ﹤0.01% 2526
2024
Q4 		$1.44M Sell
456,022
-5,800
-1% -$13.1K ﹤0.01% 2274
2024
Q3 		$951K Buy
461,822
+22,600
+5% +$36.5K ﹤0.01% 2476
2024
Q2 		$641K Sell
439,222
-104,500
-19% -$194K ﹤0.01% 2576
2024
Q1 		$1.27M Buy
543,722
+145,000
+36% +$279K ﹤0.01% 2326
2023
Q4 		$805K Buy
398,722
+152,800
+62% +$641K ﹤0.01% 2544
2023
Q3 		$1.19M Buy
245,922
+41,800
+20% +$243K ﹤0.01% 2185
2023
Q2 		$1.4M Sell
204,122
-121,602
-37% -$945K ﹤0.01% 2231
2023
Q1 		$2.36M Buy
325,724
+74,502
+30% +$796K ﹤0.01% 1926
2022
Q4 		$3.22M Buy
251,222
+7,300
+3% +$95.3K ﹤0.01% 1767
2022
Q3 		$3.45M Buy
243,922
+70,400
+41% +$925K ﹤0.01% 1671
2022
Q2 		$2.14M Buy
173,522
+34,000
+24% +$505K ﹤0.01% 2138
2022
Q1 		$2.37M Buy
139,522
+11,000
+9% +$211K ﹤0.01% 2114
2021
Q4 		$3.1M Sell
128,522
-37,133
-22% -$932K ﹤0.01% 1831
2021
Q3 		$4.87M Sell
165,655
-6,635
-4% -$202K 0.01% 1483
2021
Q2 		$4.37M Buy
172,290
+42,854
+33% +$979K 0.01% 1711
2021
Q1 		$2.5M Buy
129,436
+9,500
+8% +$219K ﹤0.01% 2075
2020
Q4 		$1.76M Buy
119,936
+20,924
+21% +$447K ﹤0.01% 2199
2020
Q3 		$2.23M Sell
99,012
-22,046
-18% -$464K ﹤0.01% 2065
2020
Q2 		$2.27M Buy
121,058
+90,949
+302% +$1.19M ﹤0.01% 2119
2020
Q1 		$248K Buy
30,109
+2,967
+11% +$27.4K ﹤0.01% 3037
2019
Q4 		$254K Buy
27,142
+16,449
+154% +$137K ﹤0.01% 3117
2019
Q3 		$109K Buy
10,693
+6,493
+155% +$72K ﹤0.01% 3253
2019
Q2 		$57K Buy
+4,200
New +$63.7K ﹤0.01% 3440

Other funds holding WHWK

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Renaissance Technologies's WHWK Position: Q1 2026 in Review

Renaissance Technologies reduced its Whitehawk Therapeutics (WHWK) stake by 2.7% in Q1 2026, selling an estimated $37.9K and leaving 428,622 shares worth $1.48M. The position accounts for ﹤0.01% of the portfolio, ranked #2055.

Renaissance Technologies first reported a position in WHWK in Q2 2019 and has held it in 28 quarters since. The position peaked at $4.87M in Q3 2021. 62 funds tracked by Wall St. Rank hold WHWK as of Q1 2026.

  • Renaissance Technologies held 428,622 shares of Whitehawk Therapeutics worth $1.48M as of Q1 2026.
  • Renaissance Technologies sold 12,100 Whitehawk Therapeutics shares in Q1 2026, an estimated $37.9K.
  • Whitehawk Therapeutics made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #2055 holding.
  • Renaissance Technologies first reported a position in Whitehawk Therapeutics in Q2 2019 and has held it in 28 quarters since.
  • Renaissance Technologies's Whitehawk Therapeutics position peaked at $4.87M in Q3 2021.
  • 62 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.